Previous Close | 146.07 |
Open | 146.60 |
Bid | 143.68 x 100 |
Ask | 143.87 x 100 |
Day's Range | 143.52 - 147.49 |
52 Week Range | 143.50 - 218.88 |
Volume | |
Avg. Volume | 848,977 |
Market Cap | 18.184B |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
It hasn't been the best quarter for Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders, since the share price...
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]